SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is experiencing a sharp sell-off following news that a key customer, Marvell, canceled orders citing confidentiality breaches by the company's CFO. The community is actively debating the future of the firm's leadership and the long-term viability of its technology, with many investors expressing deep frustration over the timing of the disclosure relative to recent stock price volatility.

APE fuels culture. Backed by the best club in the world and hundreds of thousands of holders worldwide, it’s the token for digital and IRL communities, builders, creators, collectors, gamers, and beyond.  APE is the native gas token of ApeChain and is available across multiple ecosystems including Ethereum, Arbitrum, Solana and HyperLiquid.z  ApeCoin's mission is is to supercharge its ecosystem by supporting high-quality builders &amp; reinforcing 3 core pillars: ApeChain, Bored Ape Yacht Club, and Otherside.

ApeCoin

ApeCoin is seeing heightened social media activity and volatile price action as traders debate the legitimacy of recent pump-and-dump patterns, with many discussing the impact of large whale movements and potential insider manipulation. The community remains deeply divided between those calling the asset a long-term trap or "scam" and others attempting to time the market for quick, high-leverage gains.

Moolec Science SA engages in the development and production of science-based food ingredients. Its products include pet food, animal feed, and dietary supplements. It operates through the following segments: Seed and Integrated Products, Crop Protection, Crop Nutrition, and Emerging Solutions. The company was founded by Gastón Paladini, Henk Hoogenkamp, and Martin Salinas in 2020 and is headquartered in George Town, Cayman Islands.

Moolec Science SA

Moolec Science SA is trending due to significant trading activity driven by speculative interest in its low-float status and perceived short-squeeze potential. Community sentiment remains highly polarized, with active discussions focusing on technical price action and sharp volatility while some market participants express skepticism regarding the company's financials and long-term outlook.

Canadian Solar, Inc. engages in the manufacture of solar photovoltaic modules, provision of solar energy and battery storage solutions, and development of utility-scale solar and battery storage products. It operates through the CSI Solar and Global Energy segments. The CSI Solar segment designs, develops, and manufactures solar ingots, wafers, cells, modules, and other solar power and battery storage products. The Global Energy segment includes solar and battery storage project development and sale, asset management services for operational projects, sale of electricity, and investment in retained assets. The company was founded by Shawn Qu in October 2001 and is headquartered in Kitchener, Canada.

Canadian Solar Inc

Canadian Solar is trending as investors react to a significant profitability rebound driven by U.S. tariff refunds, fueling debates over whether the company is undervalued or facing systemic debt risks. While the community remains polarized by aggressive options activity and concerns over the stock's recent performance compared to its sector peers, the primary focus is on how U.S. manufacturing expansion and pending project sales will impact future profitability.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is trending as retail and institutional investors react to reports of a partnership with Google to co-develop custom AI inference chips. The community is actively debating the reliability of these reports and their potential to disrupt the current semiconductor competitive landscape, while simultaneously analyzing the company's broader role in AI infrastructure buildouts.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

Semiconductor stocks are experiencing a record-breaking, parabolic rally that has left the sector significantly overextended and detached from traditional valuation metrics. The community is sharply divided between those betting on an imminent mean reversion and those warning that fighting the current momentumoften referred to as an AI-driven 'bubble'has resulted in significant losses for short-sellers.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

Direxion Daily Semiconductor Bull 3X Shares (SOXL) is experiencing a period of intense volatility and rapid price appreciation, fueled by a relentless winning streak in the semiconductor sector and speculative fervor surrounding AI infrastructure investments. The community is sharply divided between believers in a historic super-cycle and vocal bears who argue the parabolic move is an unsustainable bubble comparable to past market crashes, with many traders debating the risks of holding leveraged positions against institutional warnings of overextension.

Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The firm's technology platforms include antibody, T cell, innate immunity and siRNA, which are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. The company was founded by Robert Taylor Nelsen, Klaus Frueh, Jay Parrish, Lawrence Corey, and Louis Picker in April 7, 2016 and is headquartered in San Francisco, CA.

Vir Biotechnology Inc

Vir Biotechnology is surging following a transformative global strategic collaboration with Astellas for their prostate cancer candidate, VIR-5500, which includes significant upfront and milestone payments. While shares have experienced volatility, the community is actively debating the stock's potential for a long-term rerating versus concerns about historical patterns of post-news sell-offs and potential equity dilution.

Astera Labs, Inc. is a global semiconductor company, which engages in the provision of hardware and software solutions for AI and cloud infrastructure applications to solve data, memory, and networking bottlenecks. It operates through the following geographical segments: Taiwan, China, United States, and Other. The company was founded by Jitendra Mohan, Casey Morrison, and Sanjay Gajendra in October 2017 and headquartered in San Jose, CA.

Astera Labs Inc.

Astera Labs Inc

Astera Labs is facing significant selling pressure as investors grapple with analyst concerns over competition and ongoing insider selling, despite strong fundamental growth in AI data center connectivity. Community sentiment remains deeply divided, with many traders viewing the pullback as a buying opportunity in a critical AI infrastructure play, while others remain cautious due to the stock's recent volatility and broader sector rotation.

Terra is a decentralized financial payment network that rebuilds the traditional payment stack on the blockchain. Luna is the reserve currency of the Terra platform. It has three core functions: i) mine Terra transactions through staking, ii) ensure the price stability of Terra stablecoins and iii) provide incentives for the platform’s blockchain validators.

Terra Luna Classic

Terra Luna Classic is attracting community attention due to ongoing speculation about supply-reduction burns and potential regulatory clarity, fueling debates among holders about the project's long-term recovery and revival efforts. Investors are actively discussing the impact of exchange-led token burns and the role of new ecosystem utility projects in a potential path back to historical price levels.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Xenon Pharmaceuticals Highlights Strong Phase III Azetukalner Data, Q3 NDA Plans at Bloom Burton Conference

Xenon Pharmaceuticals (NASDAQ:XENE) provided an update on its clinical and pipeline progress at the Bloom Burton conference, with CEO Ian Mortimer highlighting recent Phase III results for lead program azetukalner, plans for regulatory filings, and continued expansion into psychiatry and pain.

Lead...

Peregrine Capital Management LLC Invests $7.84 Million in Xenon Pharmaceuticals Inc. $XENE

Peregrine Capital Management LLC acquired a new position in shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Free Report) during the fourth quarter, according to the company in its most recent...

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Given Average Recommendation of "Buy" by Brokerages

Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Get Free Report) has received a consensus recommendation of "Buy" from the nineteen analysts that are presently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, sixteen have assigned a buy rating...

Xenon Pharmaceuticals (NASDAQ:XENE) Sees Strong Trading Volume  - What's Next?

Xenon Pharmaceuticals (NASDAQ:XENE) Sees Large Volume Increase - Should You Buy...

Aberdeen Group plc Increases Stock Position in Xenon Pharmaceuticals Inc. $XENE

Aberdeen Group plc raised its stake in shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Free Report) by 29.6% in the 4th quarter, according to its most recent 13F filing with the Securities...

Xenon Pharmaceuticals Target of Unusually High Options Trading (NASDAQ:XENE)

Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Get Free Report) was the target of unusually large options trading activity on Wednesday. Traders bought 4,063 put options on the stock. This represents an...

Assenagon Asset Management S.A. Invests $5.34 Million in Xenon Pharmaceuticals Inc. $XENE

Assenagon Asset Management S.A. acquired a new stake in shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Free Report) in the fourth quarter, according to the company in its most recent Form 13F...

Xenon Pharmaceuticals (NASDAQ:XENE) Stock Price Crosses Above Fifty Day Moving Average - Time to Sell?

Xenon Pharmaceuticals (NASDAQ:XENE) Share Price Crosses Above 50-Day Moving Average - Should You Sell...

Xenon Pharma Stock Up 55% as Insider Sells $78K in Shares. Here's What Investors Should Know

Key PointsThe chief medical officer of Xenon Pharmaceuticals directly sold 1,410 common shares for a transaction value of $78,000 on March 13, 2026...

Xenon Pharmaceuticals Stock Soars 20% in 3 Months: Here's Why

XENE shares gain 20% in 3 months as positive phase III data for epilepsy drug azetukalner and pipeline progress boost outlook and investor confidence.

Xenon Pharmaceuticals, Inc. is a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions. The company's products include XEN496, XEN1101, XEN901 and XEN007. Xenon Pharmaceuticals was founded by Simon Neil Pimstone, Johannes J. P. Kastelein and Michael R. Hayden on November 5, 1996 and is headquartered in Burnaby, Canada.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$1.18	--	--	N/A
Q4 '25	-$1.19	-$1.31	-10.52%	MISSED
Q3 '25	-$1.15	-$1.15	0.21%	BEAT
Q2 '25	-$0.99	-$1.07	-8.36%	MISSED
Q1 '25	-$0.91	-$0.83	8.30%	BEAT

XENE
Xenon Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest XENE News

XENEXenon Pharmaceuticals Inc